Literature DB >> 28249785

Identifying the presence of Parkinson's disease using low-frequency fluctuations in BOLD signals.

Yan Tang1, Li Meng2, Chang-Min Wan3, Zhen-Hua Liu3, Wei-Hua Liao2, Xin-Xiang Yan3, Xiao-Yu Wang2, Bei-Sha Tang4, Ji-Feng Guo5.   

Abstract

Parkinson's disease (PD) is a chronic, progressive, and degenerative neurological disorder that is characterized by the degeneration of dopamine neurons in the substantia nigra and the formation of intracellular Lewy inclusion bodies. Resting-state functional magnetic resonance imaging (RS-fMRI) has demonstrated evidence of changes in metabolic patterns in individuals with PD. The purpose of this study was to determine whether the presence of PD could be "predicted" based on resting fluctuations in the blood oxygenation level dependent signal. We utilized RS-fMRI to measure the amplitude of low-frequency fluctuation (ALFF) and the fractional ALFF (fALFF) in 51 patients with PD and 50 age- and sex-matched healthy controls. Compared with the healthy controls, the individuals with PD exhibited altered ALFFs in the bilateral lingual gyrus and left putamen and an altered fALFF in the right cerebellum posterior lobe. Support vector machines (SVMs), which comprise a supervised pattern recognition method that enables predictions at the individual level, were trained to separate individuals with PD from healthy controls based on the ALFF and fALFF. Using the leave-one-out cross-validation method to analyze our sample, we reliably distinguished the participants with PD from the controls with 92% sensitivity and 87% specificity. Overall, these findings suggest that the SVM-neuroimaging approach may be of particular clinical value because it enables the accurate identification of PD at the individual level. RS-fMRI should be considered for development as a biomarker and an analytical tool for the evaluation of PD.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amplitude of low-frequency fluctuations; Fractional amplitude of low-frequency fluctuations; Parkinson’s disease; Resting-state functional magnetic resonance imaging

Mesh:

Year:  2017        PMID: 28249785     DOI: 10.1016/j.neulet.2017.02.056

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  22 in total

Review 1.  Long Non-coding RNAs in Parkinson's Disease.

Authors:  Chengqi Xin; Jing Liu
Journal:  Neurochem Res       Date:  2021-02-05       Impact factor: 3.996

2.  Multivariate radiomics models based on 18F-FDG hybrid PET/MRI for distinguishing between Parkinson's disease and multiple system atrophy.

Authors:  Xuehan Hu; Xun Sun; Fan Hu; Fang Liu; Weiwei Ruan; Tingfan Wu; Rui An; Xiaoli Lan
Journal:  Eur J Nucl Med Mol Imaging       Date:  2021-04-07       Impact factor: 9.236

Review 3.  MALAT1 lncRNA and Parkinson's Disease: The role in the Pathophysiology and Significance for Diagnostic and Therapeutic Approaches.

Authors:  M Abrishamdar; M S Jalali; M Rashno
Journal:  Mol Neurobiol       Date:  2022-06-04       Impact factor: 5.682

4.  A multiple-tissue-specific magnetic resonance imaging model for diagnosing Parkinson's disease: a brain radiomics study.

Authors:  Xiao-Jun Guan; Tao Guo; Cheng Zhou; Ting Gao; Jing-Jing Wu; Victor Han; Steven Cao; Hong-Jiang Wei; Yu-Yao Zhang; Min Xuan; Quan-Quan Gu; Pei-Yu Huang; Chun-Lei Liu; Jia-Li Pu; Bao-Rong Zhang; Feng Cui; Xiao-Jun Xu; Min-Ming Zhang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

5.  Alterations of regional homogeneity in Parkinson's disease with mild cognitive impairment: a preliminary resting-state fMRI study.

Authors:  Ming-Ge Li; Tie-Fang Liu; Tian-Hao Zhang; Zhi-Ye Chen; Bin-Bin Nie; Xin Lou; Zhen-Fu Wang; Lin Ma
Journal:  Neuroradiology       Date:  2019-12-10       Impact factor: 2.804

6.  Fractional amplitude of low-frequency fluctuation in patients with neovascular glaucoma: a resting-state functional magnetic resonance imaging study.

Authors:  Yu-Qing Zhang; Meng-Ying Peng; Shi-Nan Wu; Chen-Yu Yu; Si-Yi Chen; Si-Wen Tan; Yi Shao; Qiong Zhou
Journal:  Quant Imaging Med Surg       Date:  2021-05

7.  Consistent decreased activity in the putamen in Parkinson's disease: a meta-analysis and an independent validation of resting-state fMRI.

Authors:  Jue Wang; Jia-Rong Zhang; Yu-Feng Zang; Tao Wu
Journal:  Gigascience       Date:  2018-06-01       Impact factor: 6.524

8.  Shared functional neural substrates in Parkinson's disease and drug-induced parkinsonism: association with dopaminergic depletion.

Authors:  Se Won Oh; Na-Young Shin; Uicheul Yoon; Intae Sin; Seung-Koo Lee
Journal:  Sci Rep       Date:  2020-07-15       Impact factor: 4.379

Review 9.  The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.

Authors:  Alexia Polissidis; Lilian Petropoulou-Vathi; Modestos Nakos-Bimpos; Hardy J Rideout
Journal:  Biomolecules       Date:  2020-06-16

10.  Altered Functional Brain Connectomes between Sporadic and Familial Parkinson's Patients.

Authors:  Yan Tang; Xue Xiao; Hua Xie; Chang-Min Wan; Li Meng; Zhen-Hua Liu; Wei-Hua Liao; Bei-Sha Tang; Ji-Feng Guo
Journal:  Front Neuroanat       Date:  2017-11-06       Impact factor: 3.856

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.